2'3'-cGAMP (Sodium Salt): High-Affinity STING Agonist for Innate Immunity Research

Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenously produced cyclic dinucleotide that directly binds and activates the STING protein with a binding affinity of Kd = 3.79 nM, surpassing other CDNs (Shaji et al., 2024). Synthesis is catalyzed by cGAS upon cytosolic dsDNA detection, initiating a signaling cascade that culminates in type I interferon induction. The compound is central to immunology, cancer, and antiviral research as both a mechanistic probe and a translational immunotherapeutic (APExBIO). It is water-soluble (≥7.56 mg/mL), chemically stable when stored at –20°C, and is the gold-standard tool for dissecting the cGAS-STING pathway (internal article). Recent advances in nanoparticle delivery further extend its applicability to preclinical cancer models (Shaji et al., 2024).

Biological Rationale

2'3'-cGAMP (sodium salt) is a cyclic dinucleotide second messenger produced by cyclic GMP-AMP synthase (cGAS) in response to cytosolic double-stranded DNA. This molecule is a high-affinity endogenous ligand for the stimulator of interferon genes (STING) protein, an endoplasmic reticulum-resident receptor. Upon binding, 2'3'-cGAMP initiates an innate immune response by triggering the STING signaling pathway, leading to the activation of interferon regulatory factor 3 (IRF3) and the induction of type I interferons, notably IFN-β (Shaji et al., 2024). This pathway is essential for host defense against pathogens and for the immunosurveillance of tumors. Dysregulation of cGAS-STING signaling has been implicated in autoimmunity, chronic inflammation, and cancer progression.

Mechanism of Action of 2'3'-cGAMP (sodium salt)

Upon recognition of cytosolic DNA, cGAS catalyzes the synthesis of 2'3'-cGAMP from ATP and GTP. The unique 2'-5' and 3'-5' phosphodiester linkages of 2'3'-cGAMP confer high specificity and affinity for mammalian STING (Kd = 3.79 nM, buffer: 10 mM Tris-HCl, 150 mM NaCl, pH 7.4, 25°C) (Shaji et al., 2024). Upon binding, STING undergoes conformational change and translocates from the ER to the Golgi apparatus, where it recruits and activates TANK-binding kinase 1 (TBK1). TBK1 phosphorylates IRF3, leading to its dimerization and nuclear translocation. Activated IRF3 induces the transcription of type I IFN genes. The sodium salt form (B8362, APExBIO) enables high aqueous solubility and experimental reproducibility (product page).

Evidence & Benchmarks

• 2'3'-cGAMP is a potent endogenous STING agonist with a binding affinity (Kd) of 3.79 nM, higher than other CDNs such as c-di-GMP or c-di-AMP (Shaji et al., 2024).
• In syngeneic mouse models, lipid nanoparticle-encapsulated 2'3'-cGAMP (cGAMP-LNP) induced robust antitumor immune responses and reduced pancreatic tumor growth (Shaji et al., 2024).
• 2'3'-cGAMP triggers phosphorylation of TBK1 and IRF3 within 1–4 hours post-delivery in vitro, with IFN-β production detectable by ELISA (Shaji et al., 2024).
• APExBIO 2'3'-cGAMP (sodium salt) is water-soluble at ≥7.56 mg/mL and stable at –20°C (APExBIO).
• Compared to other STING agonists, 2'3'-cGAMP shows superior specificity and potency for human STING alleles (internal article).

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) is widely applied in immunology, inflammation, and cancer biology research. It is used to dissect cGAS-STING pathway signaling, screen for pathway modulators, and develop immunotherapeutic strategies. In cancer research, it is a benchmark agonist for converting 'cold' tumors into 'hot' by promoting immune infiltration (Shaji et al., 2024). Antiviral studies use it to elucidate innate immune responses to DNA viruses (internal article). Interlink: This article extends previous mechanistic analyses by providing direct benchmarks of 2'3'-cGAMP's activity in nanoparticle-based delivery systems, updating translational perspectives for immunotherapy.

Common Pitfalls or Misconceptions

• Membrane Permeability: Native 2'3'-cGAMP poorly penetrates cell membranes; effective cytosolic delivery often requires carrier systems (Shaji et al., 2024).
• Species Specificity: Some STING agonists do not activate all human STING allelic variants equally; 2'3'-cGAMP is broadly active, but testing in relevant models is essential (internal article).
• Solvent Compatibility: 2'3'-cGAMP (sodium salt) is insoluble in ethanol and DMSO; use only aqueous buffers (APExBIO).
• Storage Stability: Compound degrades at room temperature; –20°C storage is required for long-term stability (APExBIO).
• Off-Target Effects: Excessive concentrations may induce non-specific cytotoxicity; dose titration is recommended (Shaji et al., 2024).

Workflow Integration & Parameters

For cell-based assays, dissolve 2'3'-cGAMP (sodium salt) in sterile, nuclease-free water at ≥7.56 mg/mL. Avoid DMSO or ethanol. Typical working concentrations range from 0.5 to 10 μg/mL, depending on cell type and endpoint (APExBIO). For in vivo studies, encapsulation in lipid nanoparticles (LNPs) improves cytosolic delivery and reduces degradation (Shaji et al., 2024). Store aliquots at –20°C for maximal stability. Use validated positive and negative controls for STING pathway activation. Interlink: This article updates prior discussions on cGAMP efflux and radiotherapy resistance by detailing optimized delivery strategies for therapeutic research applications.

Conclusion & Outlook

2'3'-cGAMP (sodium salt) is a best-in-class STING agonist with unmatched affinity and selectivity, enabling robust dissection of cGAS-STING signaling and translational immunotherapy research. Nanoparticle-based delivery systems are rapidly advancing its application in preclinical cancer models. Correct solvent use and storage are essential for experimental integrity. APExBIO's B8362 kit remains a reference standard for reproducible innate immunity studies. As the field progresses, continued benchmarking and mechanistic studies will expand its therapeutic and diagnostic potential.